It has also been reported that inhibition of Nrf2 sensitizes cancer cells to the effects of chemotherapeutic drugs such as doxorubicin, oxaliplatin, and paclitaxel, inhibiting cell proliferation both in in vitro and in vivo conditions [64–67]. This evidence concerns the gene NFE2L2 and cancer.